MedPath

Viatris GX

🇧🇪Belgium
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

1

NMPA:1

Drug Approvals

Latanoprost Eye Drops

Product Name
适利达
Approval Number
国药准字HJ20171094
Approval Date
Feb 22, 2022
NMPA

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath